MCK McKesson Corporation

McKesson Announces Final Voting Results from 2017 Annual Meeting of Stockholders

McKesson Corporation (NYSE:MCK) today announced results from its recent proxy vote, available in the Form 8-K filed with the Securities and Exchange Commission. McKesson’s shareholders reelected all board members by wide margins. While the shareholders did not support the current executive compensation program, they defeated shareholder proposals on an independent chair and on written consent by significant margins.

Chief Executive Officer and Chairman John H. Hammergren received strong support from shareholders as the chair of the Board with a 96.5% approval and with the defeat of the shareholder proposal to split the CEO and chair roles.

Regarding executive compensation, the Board’s Compensation Committee plans to conduct a thorough review of the current program, have discussions with shareholders about any recommended changes and, as evidenced over the years, continue to make changes designed to further drive alignment between our incentives and shareholder value creation.

“We value our shareholders’ feedback as we work to deliver ever-increasing value to our investors and our customers,” said Mr. Hammergren. “I am incredibly proud of the 70,000 McKesson employees who work every day to deliver better health to our customers and the patients they serve.”

About McKesson Corporation

McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

EN
28/07/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on McKesson Corporation

Mckesson Corp: 1 director

A director at Mckesson Corp sold 11,930 shares at 705.630USD and the significance rating of the trade was 91/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 25 February 2025 in which we reassessed the appropriateness of the ratings in the cont...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch